Clinical Trials

152 enrolled

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07207824 2025-10-06

HERO

182 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT07199855 2025-09-30

Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia

Phase 2 Active not recruiting

24 enrolled

Burkitt Lymphoma

NCT05051631 2025-08-28

BRAVE

Phase NA Completed

1,071 enrolled 11 charts

Breast

Breast Neoplasms

NCT07014202 2025-07-30

Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy

224 enrolled

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT07094464 2025-07-30

Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation

20 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05827549 2025-06-06

ReCALL

90 enrolled

Phase 2 Not yet recruiting

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05375708 2025-03-28

SIRIUS

Phase 2 Suspended

93 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT06827353 2025-02-14

OVNI-B

Recruiting

300 enrolled

Gynecologic

Carcinoma, Ovarian Neoplasms

NCT06744894 2024-12-20

SIL as Maintenance Therapy in Multiple Myeloma

50 enrolled

Phase NA Enrolling by invitation

Multiple Myeloma

NCT06714084 2024-12-03

CNCMT

20 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06503263 2024-09-19

Zanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL

240 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT06341556 2024-09-04

A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma

52 enrolled

Lymphoma, Mantle-Cell

NCT06277050 2024-04-30

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Phase 3 Recruiting

264 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02396043 2023-06-18

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

Phase 2 Unknown

50 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05641870 2022-12-12

Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC

Unknown

80 enrolled

Lung Neoplasms

NCT02063685 2022-06-21

Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma

807 enrolled

Lymphoma, Follicular

NCT03847727 2020-01-18

Bendamustine and Rituximab (BR) as Induction and Maintenance in Relapsed and Refractory Chronic Lymphocytic Leukemia

Unknown

112 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01554852 2018-06-11

Myeloma XI

Phase 3 Unknown

4,420 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT03489616 2018-04-05

CRAGMOLC

Phase NA Unknown

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02919462 2018-01-16

HighTySy

Phase 2 Terminated

2 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT02858258 2017-12-19

ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma

Phase 3 Recruiting

870 enrolled

Lymphoma, Mantle-Cell

NCT02296398 2016-03-11

Long-term Use of Romidepsin in Patients With CTCL

Completed

47 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT00480363 2013-07-31

QUIREDEX

120 enrolled

Smoldering Multiple Myeloma, Multiple Myeloma

NCT01665001 2012-08-17

Personalized Therapy of Precursor Lymphoid Neoplasms

Phase 2 Unknown

200 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00560053 2008-11-27

Pethema Multiple Myeloma 2000

500 enrolled

Multiple Myeloma

NCT00599937 2008-01-24

APL93: Timing of CxT and Role of Maintenance